65 related articles for article (PubMed ID: 22510377)
21. A ROS rheostat for cell fate regulation.
Maryanovich M; Gross A
Trends Cell Biol; 2013 Mar; 23(3):129-34. PubMed ID: 23117019
[TBL] [Abstract][Full Text] [Related]
22. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.
Kheirollahi M; Mehr-Azin M; Kamalian N; Mehdipour P
Med Oncol; 2011 Mar; 28(1):7-14. PubMed ID: 20077038
[TBL] [Abstract][Full Text] [Related]
23. Variation in DNA damage response pathway activity: focus on intermediate phenotype instead of genetic polymorphisms.
van Heemst D
Cell Cycle; 2011 Jun; 10(11):1714. PubMed ID: 21537112
[No Abstract] [Full Text] [Related]
24. Trp53 deficiency protects against acute intestinal inflammation.
Spehlmann ME; Manthey CF; Dann SM; Hanson E; Sandhu SS; Liu LY; Abdelmalak FK; Diamanti MA; Retzlaff K; Scheller J; Rose-John S; Greten FR; Wang JY; Eckmann L
J Immunol; 2013 Jul; 191(2):837-47. PubMed ID: 23772033
[TBL] [Abstract][Full Text] [Related]
25. ATM targets hnRNPK to control p53.
Blasius M; Bartek J
Cell Cycle; 2013 Apr; 12(8):1162-3. PubMed ID: 23549171
[No Abstract] [Full Text] [Related]
26. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system.
Song H; Chung SK; Xu Y
Cell Stem Cell; 2010 Jan; 6(1):80-9. PubMed ID: 20074536
[TBL] [Abstract][Full Text] [Related]
27. Effects of EDD on p53 function are context-specific.
Watts CK; Saunders DN
J Biol Chem; 2011 Jul; 286(28):le13; author reply le14. PubMed ID: 21757764
[No Abstract] [Full Text] [Related]
28. TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy.
Vernole P; Neale MH; Barcaroli D; Munarriz E; Knight RA; Tomasini R; Mak TW; Melino G; De Laurenzi V
Cell Cycle; 2009 Feb; 8(3):421-9. PubMed ID: 19182530
[TBL] [Abstract][Full Text] [Related]
29. Fine-tuning the p53 response to DNA damage: a new piece in the puzzle.
Polo SE
Cell Cycle; 2013 May; 12(9):1337-8. PubMed ID: 23588075
[No Abstract] [Full Text] [Related]
30. P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancers.
Ruan X; Zuo Q; Jia H; Chau J; Lin J; Ao J; Xia X; Liu H; Habib SL; Fu C; Li B
J Mol Cell Biol; 2015 Apr; 7(2):105-18. PubMed ID: 25757624
[TBL] [Abstract][Full Text] [Related]
31. DNA repair: A sensor for chromatin damage.
David R
Nat Rev Mol Cell Biol; 2013 Jul; 14(7):400-1. PubMed ID: 23736680
[No Abstract] [Full Text] [Related]
32. The role of ATM in response to metformin treatment and activation of AMPK.
Yee SW; Chen L; Giacomini KM
Nat Genet; 2012 Mar; 44(4):359-60. PubMed ID: 22456732
[No Abstract] [Full Text] [Related]
33. The role of ATM in response to metformin treatment and activation of AMPK.
Zhou K; Bellenguez C; Sutherland C; Hardie G; Palmer C; Donnelly P; Pearson E
Nat Genet; 2012 Mar; 44(4):361-2. PubMed ID: 22456734
[No Abstract] [Full Text] [Related]
34. The role of ATM in response to metformin treatment and activation of AMPK.
Woods A; Leiper JM; Carling D
Nat Genet; 2012 Mar; 44(4):360-1. PubMed ID: 22456733
[No Abstract] [Full Text] [Related]
35. Identifying players in the functional network around pRB.
Tschöp K; Dyson N
Cell Cycle; 2011 Nov; 10(22):3814-5. PubMed ID: 22142859
[No Abstract] [Full Text] [Related]
36. A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by
Yang Z; Hou Y; Hao T; Rho HS; Wan J; Luan Y; Gao X; Yao J; Pan A; Xie Z; Qian J; Liao W; Zhu H; Zhou X
Mol Cell Proteomics; 2017 Mar; 16(3):469-484. PubMed ID: 28087594
[No Abstract] [Full Text] [Related]
37. The Hippo-p53 pathway in megakaryopoiesis.
Suraneni PK; Crispino JD
Haematologica; 2016 Dec; 101(12):1446-1448. PubMed ID: 27903710
[No Abstract] [Full Text] [Related]
38. A new role of p53 in regulating lipid metabolism.
Wang X; Zhao X; Gao X; Mei Y; Wu M
J Mol Cell Biol; 2013 Apr; 5(2):147-50. PubMed ID: 23258697
[No Abstract] [Full Text] [Related]
39. Jan van Deursen: From knockout pioneer to antiaging innovator.
van Deursen J; Powell K
J Cell Biol; 2015 Aug; 210(3):366-7. PubMed ID: 26240180
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel senolytic by precise disruption of FOXO4-p53 complex.
Tripathi U; Chaib S; Gerdes EOW; Hogan KA; Zhu Y
EBioMedicine; 2021 Dec; 74():103693. PubMed ID: 34768086
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
